Melanoma drug becomes first cell therapy approved to treat a solid tumor, and a new method for treating mesothelioma extended patient survival in a recent trial.

by Thomas Celona

Researchers explore a try-everything approach to precision medicine, and physical activity may help ease cancer pain.

by Kevin McLaughlin

Patients and doctors urge researchers to study lower doses for cancer treatments, and the FDA faces criticism for not issuing a formaldehyde ban in hair straighteners.

by Marci A. Landsmann

Improving fitness linked to lower prostate cancer risk, and a study from Scotland finds no cervical cancer cases in women vaccinated before age 14.

by Eric Fitzsimmons

Questions about screening for women with dense breast tissue, and the FDA asks drugmakers to add a warning to labels for CAR T-cell therapies.

by Thomas Celona

Preventive gastrectomy has lasting effects, and rising cancer incidence undercuts continued progress against mortality.

by Eric Fitzsimmons

Hiding serious illness can be a coping strategy, and cancer rates are on the rise among young people.

by Kevin McLaughlin

The FDA will review a blood test that detects colon cancer, and a writer recounts his sister’s decision to receive medical aid in dying.

by Marci A. Landsmann

Study finds breast cancer survivors can opt for less frequent screening, and people with physical disabilities often encounter discrimination in cancer care.

by Thomas Celona

Less radiation explored in multiple studies at San Antonio Breast Cancer Symposium, and National Cancer Institute writes next precision medicine chapter.

by Marci A. Landsmann